Wanfu Biotechnology: Obtained the medical device product registration certificate

On the evening of July 20th, Wanfu Biotechnology announced that the company has recently received the medical device registration certificate for the human microsatellite instability test kit issued by the National Medical Products Administration. MSI testing is of great significance for patients with various solid tumors, including screening for Lynch syndrome, selecting 5-FU chemotherapy drugs, stratifying prognosis, and identifying populations that benefit from immune checkpoint inhibitors.